SCHEMBL13375744

SCHEMBL13375744

CCCCCNC(=O)c1ccc(CCC)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.69
▸ NAAA Q02083 2/20 0.66
▸ PLK1 P53350 2/20 0.62
▸ MLYCD O95822 1/20 0.61
▸ TMEM97 Q5BJF2 2/20 0.61
▸ SIGMAR1 Q99720 2/20 0.61
▸ CA2 P00918 1/20 0.60
▸ HDAC3 O15379 2/20 0.58
▸ THRA P10827 1/20 0.57
▸ THRB P10828 1/20 0.57
▸ MEN1 O00255 2/20 0.56
▸ KMT2A Q03164 2/20 0.56
▸ ALDH1A1 P00352 2/20 0.56
▸ NPC1 O15118 2/20 0.56
▸ RAB9A P51151 2/20 0.56
▸ MAPT P10636 1/20 0.56
▸ SMN1; SMN2 Q16637 1/20 0.56
▸ POLB P06746 2/20 0.55
▸ CTDSP1 Q9GZU7 2/20 0.55
▸ KDM4E B2RXH2 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13375750 0.98 L3MBTL1 (0.71) L3MBTL1NAAAPLK1MLYCDTMEM97
SCHEMBL10950073 0.95 PLK1 (0.64) L3MBTL1NAAAPLK1MLYCDTMEM97
SCHEMBL9784422 0.92 L3MBTL1 (0.71) L3MBTL1NAAAPLK1MLYCDTMEM97
SCHEMBL9491031 0.92 L3MBTL1 (0.71) L3MBTL1NAAAPLK1MLYCDTMEM97
SCHEMBL10949132 0.88 PLK1 (0.70) L3MBTL1NAAAPLK1MLYCDTMEM97
SCHEMBL15166526 0.88 L3MBTL1 (0.71) L3MBTL1NAAAPLK1MLYCDCA2
SCHEMBL10950404 0.88 PLK1 (0.68) PLK1TMEM97SIGMAR1CA2MEN1
SCHEMBL6535660 0.88 L3MBTL1 (0.86) L3MBTL1NAAAMLYCDCA2HDAC3
SCHEMBL9265536 0.88 L3MBTL1 (0.86) L3MBTL1NAAAMLYCDCA2HDAC3
SCHEMBL845966 0.88 L3MBTL1 (0.86) L3MBTL1NAAAMLYCDCA2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8288339-B2 GLP-1 compounds AMGEN INC. (US) 2012-10-16 — — US disclosed
US-20100048468-A1 GLP-1 COMPOUNDS AMGEN INC. (US) 2010-02-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048468-A1 GLP-1 COMPOUNDS GLP1R, IAPP, GIPR L3MBTL1 1069/4885NAAA 789/4885PLK1 4122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback